What are the next steps for HIV prevention and testing after completing a 28-day course of Post-Exposure Prophylaxis (PEP) for HIV exposure?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 22, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

HIV Testing and Prevention After Completing PEP

After completing your 28-day PEP course, you must undergo HIV testing at 4-6 weeks and again at 12 weeks post-exposure using both laboratory-based antigen/antibody tests AND nucleic acid tests (NAT) to definitively rule out HIV infection. 1, 2

Critical Testing Timeline Post-PEP

Your testing schedule depends on when you started PEP and your adherence to the full course:

First Follow-Up Test (4-6 Weeks After Starting PEP)

  • Required tests: Laboratory-based HIV antigen/antibody (Ag/Ab) combination test PLUS diagnostic HIV nucleic acid test (NAT) 1, 2
  • Purpose: This identifies HIV infection, particularly if you didn't complete the full PEP course or had poor adherence 1
  • Important caveat: A negative test at this point does NOT rule out HIV because the antiretrovirals you took can suppress the virus for more than 2 weeks after stopping 1
  • This visit is also the appropriate time to discuss starting PrEP if you have ongoing HIV risk 1

Final Definitive Test (12 Weeks After Starting PEP)

  • Required tests: Laboratory-based Ag/Ab combination immunoassay AND diagnostic HIV NAT 1, 2
  • Purpose: This is the definitive timepoint to rule out HIV infection from your exposure 1, 2
  • Timing rationale: This allows for complete antiretroviral washout and accounts for the window period of modern HIV tests 1
  • Most laboratory-based Ag/Ab tests will detect HIV acquisition from your original exposure by this time 1

Why Both Tests Are Required

The CDC specifically recommends both test types because:

  • HIV NAT detects infection approximately 1 week earlier than Ag/Ab tests (around 10-14 days post-infection versus 18-45 days) 2
  • Antiretrovirals taken as PEP can suppress HIV viral load, delay seroconversion, and decrease the ability to detect HIV infection 1
  • Using both tests together maximizes sensitivity for detecting HIV at a time when you are highly infectious if infected 1
  • Diagnostic NATs are preferred over standard viral load assays because they detect lower levels of HIV 2

Optional Earlier Testing Scenario

You may defer the 4-6 week test ONLY if all of the following apply 1:

  • You started PEP within 24 hours of exposure
  • You were fully adherent to the complete 28-day course
  • You are NOT considering starting PrEP

However, you still MUST complete the final 12-week testing regardless 1.

Extended Follow-Up Situations

You need 12-month extended follow-up (not just 6 months) if 1, 3:

  • The source person was coinfected with both HIV and HCV, AND
  • You became infected with hepatitis C after the exposure 1, 3

Transitioning to PrEP

If you have ongoing HIV risk, you can start PrEP immediately after completing PEP without waiting for the 12-week test 1. However, you must:

  • Be counseled about the possibility of a false-negative HIV test result 1
  • Understand the importance of ongoing PrEP care with recommended HIV testing 1
  • Complete the 12-week post-PEP HIV testing even after starting PrEP 1

Critical Testing Pitfalls to Avoid

Never rely on rapid antibody-only tests during your follow-up period, as they are less sensitive than laboratory-based tests 1, 2. Oral fluid-based rapid HIV tests are specifically NOT recommended in the PEP context because they miss acute or recent infections 1.

Never stop follow-up testing before 12 weeks when using modern Ag/Ab and NAT testing—this is the definitive timepoint to rule out infection 2.

Never use antibody testing alone if you've recently taken antiretrovirals, as they can delay or suppress antibody development 2.

Immediate Testing If Symptoms Develop

Seek immediate HIV testing if you develop symptoms compatible with acute retroviral syndrome (fever, rash, lymphadenopathy, pharyngitis, myalgias) at ANY time, regardless of your testing schedule 1, 3. Acute HIV infection can present before antibodies are detectable.

Other STI Testing

Since any exposure that warranted PEP also places you at risk for other sexually transmitted infections, you should be tested for other STIs according to CDC STI Treatment Guidelines 1.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

HIV Window Period for Accurate Testing After Exposure

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

HIV Testing Follow-Up After Occupational Exposure: Current Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What is the recommended post-exposure prophylaxis (PEP) regimen after a needle stick injury with an HIV patient who has an undetectable viral load?
What is the recommended post-exposure prophylaxis (PEP) regimen for individuals potentially exposed to Human Immunodeficiency Virus (HIV)?
What are the next steps after taking Post-Exposure Prophylaxis (PEP) for HIV exposure?
What is post-exposure prophylaxis (PEP) and how is it used to prevent disease after potential exposure to a health risk, such as Human Immunodeficiency Virus (HIV)?
What is the recommended Post-Exposure Prophylaxis (PEP) regimen for individuals potentially exposed to Human Immunodeficiency Virus (HIV)?
What are the next steps after taking Post-Exposure Prophylaxis (PEP) for HIV exposure?
Is cefixime (Cefixime) 400mg once a day and doxycycline (Doxycycline) 100mg twice a day an appropriate treatment regimen for a patient diagnosed with urethritis?
What is the recommended treatment for a patient with Hepatitis B (infectious liver disease caused by Hepatitis B virus)?
In an elderly male patient with an Artery of Percheron infarct, tracheostomised, having pneumonia, currently on low molecular weight heparin (LMWH) for paroxysmal atrial fibrillation, should LMWH be continued throughout the Intensive Care Unit (ICU) stay or can it be switched to a non-vitamin K antagonist oral anticoagulant (NOAC), such as apixaban (apixaban), rivaroxaban (rivaroxaban), or dabigatran (dabigatran), or warfarin (warfarin) during the ICU stay?
What is the antidote for a clonazepam (Klonopin) overdose?
What is the diagnosis for a patient who develops hypotension and decreased oxygen saturation (SpO2) of 88% within 15 minutes after a blood transfusion?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.